Takayuki Chikata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Takayuki Chikata has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Masafumi Takiguchi
Division of International Collaboration Research and Tokyo Laboratory, Joint Research Center for Human Retrovirus Infection, Kumamoto University , 2-2-1 Honjo, Chuo-ku, Kumamoto 860-0811
5 shared publications Giang Van Tran
Joint Research Center for Human Retrovirus Infection, Kumamoto University , Kumamoto
3 shared publicationsShinichi Oka
AIDS Clinical Center, National Center for Global Health and Medicine, Japan Institute for Health Security , Tokyo 162-8655
3 shared publications- Hiroyuki Gatanaga
AIDS Clinical Center, National Center for Global Health and Medicine, Japan Institute for Health Security , Tokyo
2 shared publications - Hung The Nguyen
Division of International Collaboration Research and Tokyo Laboratory, Joint Research Center for Human Retrovirus Infection, Kumamoto University , 2-2-1 Honjo, Chuo-ku, Kumamoto 860-0811
2 shared publications - Nozomi Kuse
Division of International Collaboration Research and Tokyo Joint Laboratory, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto/Tokyo, Japan
2 shared publications
Latest Publications
- Open Access
- 7 April 2026
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 5 (4)
Multistep coevolution of HIV-1 and human leukocyte antigen-C-restricted HIV-1-specific CD8+ T cells and the association with disease progression
Disease progression during HIV-1 infection is proposed to correlate with the accumulation of virus variants that have evaded HIV-1-specific T cells; however, the multistep coevolution of HIV-1 with HIV-1-specific T cells has not been well investigated. Here, we analyzed the coevolution of HIV-1 with human leukocyte antigen (HLA)-C*14-restricted HIV-1-specific T cells in treatment-naive HLA-C*14+ people living with HIV-1 (PLWH). The analyses of T cells specific for NefYT9 wild-type (WT) or escape mutant epitopes and HIV-1 sequences in HLA-C*14+ PLWH suggested that NefQ125H was first selected by NefYT9 WT–specific T cells, then NefQ125D was selected by NefYT9-6H-specific T cells. This coevolution was confirmed by longitudinal analysis of HLA-C*14+ PLWH. The CD4 count in NefQ125D virus–infected HLA-C*14+ individuals was significantly lower than that in WT-virus–infected HLA-C*14+ individuals, suggesting that accumulation of the NefQ125D mutant epitope correlates with disease progression. Our findings demonstrate that the multistep coevolution of HIV-1 with HLA-C-restricted HIV-1-specific T cells is associated with disease progression in HIV-1 infection.
- 7 April 2026
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 5 (4)
Open AccessMultistep coevolution of HIV-1 and human leukocyte antigen-C-restricted HIV-1-specific CD8+ T cells and the association with disease progression
Disease progression during HIV-1 infection is proposed to correlate with the accumulation of virus variants that have evaded HIV-1-specific T cells; however, the multistep coevolution of HIV-1 with HIV-1-specific T cells has not been well investigated. Here, we analyzed the coevolution of HIV-1 with human leukocyte antigen (HLA)-C*14-restricted HIV-1-specific T cells in treatment-naive HLA-C*14+ people living with HIV-1 (PLWH). The analyses of T cells specific for NefYT9 wild-type (WT) or escape mutant epitopes and HIV-1 sequences in HLA-C*14+ PLWH suggested that NefQ125H was first selected by NefYT9 WT–specific T cells, then NefQ125D was selected by NefYT9-6H-specific T cells. This coevolution was confirmed by longitudinal analysis of HLA-C*14+ PLWH. The CD4 count in NefQ125D virus–infected HLA-C*14+ individuals was significantly lower than that in WT-virus–infected HLA-C*14+ individuals, suggesting that accumulation of the NefQ125D mutant epitope correlates with disease progression. Our findings demonstrate that the multistep coevolution of HIV-1 with HLA-C-restricted HIV-1-specific T cells is associated with disease progression in HIV-1 infection.
- Open Access
- 2 February 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (2)
Frequent Detection of HIV-1 Variants With Mixed Coreceptor Usage Among People Who Inject Drugs Infected With CRF01_AE: Possible Association With Coreceptor Switch
Background: Our previous study suggested that mixed infection with R5 and X4/dual human immunodeficiency virus type 1 (HIV-1) may contribute to coreceptor switch from R5 to X4 HIV-1. To confirm this hypothesis, we investigated mixed HIV-1 infections in people who inject drugs (PWID) infected with the CRF01_AE subtype. Methods: Viral plasma RNA from PWID were extracted, the V3 region of the HIV-1 gp120 gene was amplified, and deep sequencing was performed. Coreceptor usage was determined using phenotypic assay by cloning each V3 region. Coreceptor usage of minor HIV-1 variants detected by deep sequencing was predicted based on the amino acid sequences of the V3 region. Results: Deep sequencing of plasma from 36 PWID revealed that mixed HIV-1 infection involving different coreceptor usage occurred in 13 cases (36.1%). Phylogenetic analysis revealed that R5 variants were dominant, whereas X4/dual variants were detected as minor populations in most cases. In 1 case, however, R5 variants emerged as a distinct minor population mixed with X4/dual variants as the major population. Notably, plasma viral RNA load (pVL) was higher in cases of mixed infection with R5 and X4/dual HIV-1 than in those infected solely with R5 HIV-1. Conclusions: Our observations suggest a possible association between mixed HIV-1 coreceptor usage and coreceptor switch in CRF01_AE–infected PWID, and that mixed infection may be associated with pVL.
- 2 February 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (2)
Open AccessFrequent Detection of HIV-1 Variants With Mixed Coreceptor Usage Among People Who Inject Drugs Infected With CRF01_AE: Possible Association With Coreceptor Switch
Background: Our previous study suggested that mixed infection with R5 and X4/dual human immunodeficiency virus type 1 (HIV-1) may contribute to coreceptor switch from R5 to X4 HIV-1. To confirm this hypothesis, we investigated mixed HIV-1 infections in people who inject drugs (PWID) infected with the CRF01_AE subtype. Methods: Viral plasma RNA from PWID were extracted, the V3 region of the HIV-1 gp120 gene was amplified, and deep sequencing was performed. Coreceptor usage was determined using phenotypic assay by cloning each V3 region. Coreceptor usage of minor HIV-1 variants detected by deep sequencing was predicted based on the amino acid sequences of the V3 region. Results: Deep sequencing of plasma from 36 PWID revealed that mixed HIV-1 infection involving different coreceptor usage occurred in 13 cases (36.1%). Phylogenetic analysis revealed that R5 variants were dominant, whereas X4/dual variants were detected as minor populations in most cases. In 1 case, however, R5 variants emerged as a distinct minor population mixed with X4/dual variants as the major population. Notably, plasma viral RNA load (pVL) was higher in cases of mixed infection with R5 and X4/dual HIV-1 than in those infected solely with R5 HIV-1. Conclusions: Our observations suggest a possible association between mixed HIV-1 coreceptor usage and coreceptor switch in CRF01_AE–infected PWID, and that mixed infection may be associated with pVL.
- Open Access
- 6 November 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-16
Molecular basis for selection and inhibition of HIV-1 escape virus by T cells and KIR2DL2+NK cells
NK cells and CD8+ T cells both contribute to HIV-1 control. These cells not only suppress HIV-1 replication, but also select HIV-1 escape mutant viruses. Most viruses bearing T cell escape mutations are expected to remain susceptible to NK cell suppression, but their inhibition by NK cells is unclear. We investigated the role of HIV-1-specific CD8+ T cells and NK cells recognizing superimposed Pol peptides in selection and control of HIV-1 mutant virus. KIR2DL2+NK cells have an enhanced ability to recognize HIV-1-infected cells after selection of Pol mutant virus by PolIY11-specific HLA-C*12:02-restricted T cells. Mass spectrometry-based immunopeptidome profiling of HIV-1-infected cells and analysis of crystal structures of TCR- and KIR2DL2-HLA-C*12:02-peptide complexes demonstrate the molecular basis for selection and recognition of the escape mutant epitope by TCR and KIR2DL2. The present study elucidates the mechanism for selection and inhibition of an HIV-1 escape virus by T cells and NK cells.
- 6 November 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-16
Open AccessMolecular basis for selection and inhibition of HIV-1 escape virus by T cells and KIR2DL2+NK cells
NK cells and CD8+ T cells both contribute to HIV-1 control. These cells not only suppress HIV-1 replication, but also select HIV-1 escape mutant viruses. Most viruses bearing T cell escape mutations are expected to remain susceptible to NK cell suppression, but their inhibition by NK cells is unclear. We investigated the role of HIV-1-specific CD8+ T cells and NK cells recognizing superimposed Pol peptides in selection and control of HIV-1 mutant virus. KIR2DL2+NK cells have an enhanced ability to recognize HIV-1-infected cells after selection of Pol mutant virus by PolIY11-specific HLA-C*12:02-restricted T cells. Mass spectrometry-based immunopeptidome profiling of HIV-1-infected cells and analysis of crystal structures of TCR- and KIR2DL2-HLA-C*12:02-peptide complexes demonstrate the molecular basis for selection and recognition of the escape mutant epitope by TCR and KIR2DL2. The present study elucidates the mechanism for selection and inhibition of an HIV-1 escape virus by T cells and NK cells.
- Open Access
- 22 October 2025
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 4 (11)
HIV-1-specific CD8+ T cells with different abilities to recognize HIV-1-infected cells in HIV-1-exposed seronegative individuals
The presence of HIV-1-specific CD8+ T-cell responses in HIV-1-exposed seronegative (HESN) individuals has been reported, but the details of these T cells have yet to be analyzed. We investigated HIV-1-specific CD8+ T-cell responses to 281 17-mer overlapping HIV-1 peptides and six HLA-B*15:02-restricted HIV-1 subtype AE epitope peptides in 370 Vietnamese HESN men who have sex with men (MSM). Analysis of cultured T cells stimulated with these peptides using intracellular cytokine staining (ICS) assay demonstrated HIV-1-specific CD8+ T-cell responses in only eight of these HESN-MSM. HLA-restricted CD8+ T cells specific for five HIV-1 epitope peptides were identified in five of these individuals by ICS assay and/or assay using HLA multimers. CD8+ T cells specific for three HIV-1 peptides (GagHL9, PolSV9, and PolVF9) recognized HIV-1 subtype AE–infected cells, whereas those specific for two HIV-1 peptides did not recognize them. Among CD8+ T cells that can recognize HIV-1-infected cells, those specific for two epitopes, GagHL9 and PolSV9, were frequently elicited in HIV-1-infected individuals, whereas PolVF9-specific CD8+ T cells were not found in them. These results indicate that two types of HIV-1-specific CD8+ T cells were clearly detected in HESN-MSM; they include CD8+ T cells specific for the immunodominant or nonimmunodominant HIV-1 epitope peptide that is effectively presented in HIV-1-infected cells and those for the HIV-1 peptide that is very weakly or not presented by HLA class I in HIV-1-infected cells. The present study demonstrated the existence of different HIV-1-specific CD8+ T cells that can or cannot recognize HIV-1-infected cells before HIV-1 infection is established.
- 22 October 2025
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 4 (11)
Open AccessHIV-1-specific CD8+ T cells with different abilities to recognize HIV-1-infected cells in HIV-1-exposed seronegative individuals
The presence of HIV-1-specific CD8+ T-cell responses in HIV-1-exposed seronegative (HESN) individuals has been reported, but the details of these T cells have yet to be analyzed. We investigated HIV-1-specific CD8+ T-cell responses to 281 17-mer overlapping HIV-1 peptides and six HLA-B*15:02-restricted HIV-1 subtype AE epitope peptides in 370 Vietnamese HESN men who have sex with men (MSM). Analysis of cultured T cells stimulated with these peptides using intracellular cytokine staining (ICS) assay demonstrated HIV-1-specific CD8+ T-cell responses in only eight of these HESN-MSM. HLA-restricted CD8+ T cells specific for five HIV-1 epitope peptides were identified in five of these individuals by ICS assay and/or assay using HLA multimers. CD8+ T cells specific for three HIV-1 peptides (GagHL9, PolSV9, and PolVF9) recognized HIV-1 subtype AE–infected cells, whereas those specific for two HIV-1 peptides did not recognize them. Among CD8+ T cells that can recognize HIV-1-infected cells, those specific for two epitopes, GagHL9 and PolSV9, were frequently elicited in HIV-1-infected individuals, whereas PolVF9-specific CD8+ T cells were not found in them. These results indicate that two types of HIV-1-specific CD8+ T cells were clearly detected in HESN-MSM; they include CD8+ T cells specific for the immunodominant or nonimmunodominant HIV-1 epitope peptide that is effectively presented in HIV-1-infected cells and those for the HIV-1 peptide that is very weakly or not presented by HLA class I in HIV-1-infected cells. The present study demonstrated the existence of different HIV-1-specific CD8+ T cells that can or cannot recognize HIV-1-infected cells before HIV-1 infection is established.
- Open Access
- 1 March 2018
- Published by American Society for Microbiology in Journal of Virology
- Vol. 92 (5) , e01749-17
HLA Class I-Mediated HIV-1 Control in Vietnamese Infected with HIV-1 Subtype A/E
HIV-1-specific cytotoxic T cells (CTLs) play an important role in the control of HIV-1 subtype B or C infection. However, the role of CTLs in HIV-1 subtype A/E infection still remains unclear. Here we investigated the association of HLA class I alleles with clinical outcomes in treatment-naive Vietnamese infected with subtype A/E virus. We found that HLA-C*12:02 was significantly associated with lower plasma viral loads (pVL) and higher CD4 counts and that the HLA-A*29:01-B*07:05-C*15:05 haplotype was significantly associated with higher pVL and lower CD4 counts than those for individuals without these respective genotypes. Nine Pol and three Nef mutations were associated with at least one HLA allele in the HLA-A*29:01-B*07:05-C*15:05 haplotype, with a strong negative correlation between the number of HLA-associated Pol mutations and CD4 count as well as a positive correlation with pVL for individuals with these HLA alleles. The results suggest that the accumulation of mutations selected by CTLs restricted by these HLA alleles affects HIV control. IMPORTANCE Most previous studies on HLA association with disease progression after HIV-1 infection have been performed on cohorts infected with HIV-1 subtypes B and C, whereas few such population-based studies have been reported for cohorts infected with the Asian subtype A/E virus. In this study, we analyzed the association of HLA class I alleles with clinical outcomes for 536 HIV-1 subtype A/E-infected Vietnamese individuals. We found that HLA-C*12:02 is protective, while the HLA haplotype HLA-A*29:01-B*07:05-C*15:05 is deleterious. The individuals with HIV-1 mutations associated with at least one of the HLA alleles in the deleterious HLA haplotype had higher plasma viral loads and lower CD4 counts than those of individuals without the mutations, suggesting that viral adaptation and escape from HLA-mediated immune control occurred. The present study identifies a protective allele and a deleterious haplotype for HIV-1 subtype A/E infection which are different from those identified for cohorts infected with HIV-1 subtypes B and C.
- 1 March 2018
- Published by American Society for Microbiology in Journal of Virology
- Vol. 92 (5) , e01749-17
Open AccessHLA Class I-Mediated HIV-1 Control in Vietnamese Infected with HIV-1 Subtype A/E
HIV-1-specific cytotoxic T cells (CTLs) play an important role in the control of HIV-1 subtype B or C infection. However, the role of CTLs in HIV-1 subtype A/E infection still remains unclear. Here we investigated the association of HLA class I alleles with clinical outcomes in treatment-naive Vietnamese infected with subtype A/E virus. We found that HLA-C*12:02 was significantly associated with lower plasma viral loads (pVL) and higher CD4 counts and that the HLA-A*29:01-B*07:05-C*15:05 haplotype was significantly associated with higher pVL and lower CD4 counts than those for individuals without these respective genotypes. Nine Pol and three Nef mutations were associated with at least one HLA allele in the HLA-A*29:01-B*07:05-C*15:05 haplotype, with a strong negative correlation between the number of HLA-associated Pol mutations and CD4 count as well as a positive correlation with pVL for individuals with these HLA alleles. The results suggest that the accumulation of mutations selected by CTLs restricted by these HLA alleles affects HIV control. IMPORTANCE Most previous studies on HLA association with disease progression after HIV-1 infection have been performed on cohorts infected with HIV-1 subtypes B and C, whereas few such population-based studies have been reported for cohorts infected with the Asian subtype A/E virus. In this study, we analyzed the association of HLA class I alleles with clinical outcomes for 536 HIV-1 subtype A/E-infected Vietnamese individuals. We found that HLA-C*12:02 is protective, while the HLA haplotype HLA-A*29:01-B*07:05-C*15:05 is deleterious. The individuals with HIV-1 mutations associated with at least one of the HLA alleles in the deleterious HLA haplotype had higher plasma viral loads and lower CD4 counts than those of individuals without the mutations, suggesting that viral adaptation and escape from HLA-mediated immune control occurred. The present study identifies a protective allele and a deleterious haplotype for HIV-1 subtype A/E infection which are different from those identified for cohorts infected with HIV-1 subtypes B and C.